HEXABODY
Live / Registered — Registered — Section 71 accepted (as of 25 Feb 2025)
What this means for you
Registered since 18 Mar 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Mar 2034: the §71 ten-year affidavit of use).
Record
- Serial number
- 79124376
- Registration number
- 4496618
- Mark type
- Word mark
- Filed
- 15 Nov 2012
- Published for opposition
- 31 Dec 2013
- Registered
- 18 Mar 2014
- Next maintenance filing
- §71 ten-year affidavit of use, due by 18 Mar 2034 (grace period to 18 Sept 2034)
- Attorney of record
- Max Vern
Goods and services
- Class 001 — Chemicals: Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases
- Class 042 — Scientific and technological services: Medical, scientific and biological research; [ medical, scientific and biological ] research in [ the field of ] antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; chemical analysis [ ; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy; development of pharmaceuticals containing antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these ]
- Class 045 — Legal and security services: Legal services in the form of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine
Owner
- Genmab B.V., Utrecht, NL
- Genmab B.V., NL
- Genmab B.V., NL
- Genmab A/S, DK
Prosecution history
- 28 Jul 2026 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 28 Jul 2026 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 14 May 2026 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 29 Apr 2026 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 05 Mar 2026 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 25 Oct 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 24 Apr 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 25 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 25 Feb 2025 — REGISTERED-SEC.71 ACCEPTED
- 24 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Sept 2024 — TEAS SECTION 71 RECEIVED
- 05 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 05 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 05 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED